CCND1 and inflammatory bowel disease: Indeed, we could demonstrate that CCND1, a well-recognized β-catenin-activated gene, was expressed by ~20% of intestinal DCs and substantially downmodulated in DCs located particularly in the inflamed tissues of IBD patients (Fig. 7E).